...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.
【24h】

Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.

机译:Cbl-b通过效应CD8 T细胞调节抗原诱导的TCR下调和IFN-γ产生,而不影响功能亲和力。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The E3 ubiquitin ligase Cbl-b is a negative regulator of TCR signaling that: 1) sets the activation threshold for T cells; 2) is induced in anergic T cells; and 3) protects against autoimmunity. However, the role of Cbl-b in regulating CD8 T cell activation and functions during physiological T cell responses has not been systematically examined. Using the lymphocytic choriomeningitis virus infection model, we show that Cbl-b deficiency did not significantly affect the clonal expansion of virus-specific CD8 T cells. However, Cbl-b deficiency not only increased the steady-state cell surface expression levels of TCR and CD8 but also reduced Ag-induced down-modulation of cell surface TCR expression by effector CD8 T cells. Diminished Ag-stimulated TCR down-modulation and sustained Ag receptor signaling induced by Cbl-b deficiency markedly augmented IFN-gamma production, which is known to require substantial TCR occupancy. By contrast, Cbl-b deficiency minimally affected cell-mediated cytotoxicity, which requires limited engagement of TCRs. Surprisingly, despite elevated expression of CD8 and reduced Ag-induced TCR down-modulation, the functional avidity of Cbl-b-deficient effector CD8 T cells was comparable to that of wild-type effectors. Collectively, these data not only show that Cbl-b-imposed constraint on TCR signaling has differential effects on various facets of CD8 T cell response but also suggest that Cbl-b might mitigate tissue injury induced by the overproduction of IFN-gamma by CD8 T cells. These findings have implications in the development of therapies to bolster CD8 T cell function during viral infections or suppress T cell-mediated immunopathology.
机译:E3泛素连接酶Cbl-b是TCR信号的负调节剂,其:1)设置T细胞的激活阈值; 2)在无反应的T细胞中诱导; 3)防止自身免疫。然而,尚未系统地检查Cbl-b在调节生理性T细胞应答过程中调节CD8T细胞活化和功能中的作用。使用淋巴细胞性脉络膜脑膜炎病毒感染模型,我们显示Cbl-b缺乏并不显着影响病毒特异性CD8 T细胞的克隆扩增。但是,Cbl-b缺乏不仅增加了TCR和CD8的稳态细胞表面表达水平,而且还减少了效应CD8 T细胞的Ag诱导的细胞表面TCR表达的下调。由Cbl-b缺乏诱导的Ag刺激的TCR下调的减弱和持续的Ag受体信号转导显着增加了IFN-γ的产生,已知这需要大量的TCR占用。相反,Cbl-b缺乏对细胞介导的细胞毒性的影响最小,这要求TCR的参与有限。出人意料的是,尽管CD8的表达升高且Ag诱导的TCR下调减少,但Cbl-b缺陷效应子CD8 T细胞的功能亲和力与野生型效应子相当。总的来说,这些数据不仅表明Cbl-b对TCR信号的限制对CD8 T细胞应答的各个方面都有不同的影响,而且还表明Cbl-b可能减轻了CD8 T过度产生IFN-γ引起的组织损伤。细胞。这些发现对在病毒感染期间增强CD8 T细胞功能或抑制T细胞介导的免疫病理学的疗法的发展具有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号